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Background 
Infection of the incised skin or soft tissues is common, but can be avoided by the use of 
antibiotic prophylaxis in surgery. Some bacterial contamination of a surgical site is inevitable, 
either from the patient’s own bacterial flora or from the environment (1). The basic idea 
behind surgical wound prophylaxis is that antibiotics should already be in the tissue at the 
time the wound is inflicted. Administration of antibiotics inhibits growth of contaminating 
bacteria, and their adherence to tissues and to prosthetic implants, thus reducing the risk of 
infection (2). However antibiotics are not innocuous – apart from the cost, there is a 
substantial risk of allergy, up to and including death from anaphylaxis as well as development 
of resistance. The aim of antimicrobial prophylaxis in urological surgery is to prevent 
infective complications resulting from diagnostic and therapeutic procedures. There is no 
single-handed guideline for the use of antibiotic prophylaxis at Aker University Hospital. 
Method 
Between January 2004 and June 2004, 177 surgical procedures were studied at Oslo 
Urological University Clinic at Aker University Hospital. By reviewing medical, anaesthetic 
and nursing records, and medication charts, the antibiotic choice, duration of prophylaxis, 
dose and timing of the first dose was recorded.  
Findings 
The timing and duration of the antibiotic prophylaxis were incorrect in many cases. Among 
those who received prophylaxis, 41.5 % (39/94) were given prophylaxis after the time of 
incision, and the mean duration of prophylaxis was 5.2 days with a range of 0 days and 14 
days. There was also a variation in the dosage and type of antibiotic used in prophylaxis for 
the same kind of surgeries.  
Interpretation  
The evidence on the best choice of antibiotics and prophylactic regimens is limited. Most 
studies in the past have been poorly designed and have lacked statistical power. Obviously, 
there is a need for evidence-based guidelines, in order to standardize the antibiotic 
prophylaxis at Aker University Hospital. 
 
(1) Emmerson AM, Enstone, JE, Griffin M, Kelsey MC, Smyth ET. The Second National Prevalence Survey of infection in hospitals - 
overview of the results. J Hosp Infect 1996; 32: 175-90.  
(2) Tornqvist IO, Holm SE, Cars O. Pharmacodynamic effects of subinhibitory antibiotic concentrations. Scand J Infect Dis 1990; 74: 94-
101. 
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Introduction 
Infection of the incised skin or soft tissues is a common but avoidable complication of any 
surgical procedure. Some bacterial contamination of a surgical site is inevitable, either from 
the patient’s own bacterial flora or from the environment (1). The basic idea behind surgical 
wound prophylaxis is that antibiotics should already be in the tissue at the time the wound is 
inflicted. It has long been realised that some patients are at far greater risk of developing 
wound infection than others.  
Administration of antibiotics inhibits growth of contaminating bacteria, and their adherence to 
prosthetic implants, thus reducing the risk of infection (2). However antibiotics are not 
innocuous – apart from the cost, there is a risk of allergy, including death from unexpected 
anaphylaxis as well as the development of resistance. 
177 surgical procedures performed between January 2004 and June 2004, were studied at 
Oslo Urological Clinic at Aker University Hospital. By reviewing medical, anaesthetic and 
nursing records, and medication charts, the antibiotic choice, duration of prophylaxis, dose 
and timing of the first dose was recorded.  
 
 
Goals of antibiotic prophylaxis 
The goals of prophylactic administration of antibiotics to surgical patients are to: 
• Reduce the incidence of surgical site infections 
• Use antibiotics in a manner that is supported by evidence of effectiveness 
• Minimize the effect of antibiotics on the patient’s normal bacterial flora 
• Minimize adverse effects 
• Cause minimal change to the patient’s host defences 
It is important to emphasize that antibiotic prophylaxis is related to, not a substitute for, good 
surgical technique. Antibiotic prophylaxis should be regarded as one component of an 
effective policy for the control of nosocomial infection. Some of the characteristics of an 
optimal antibiotic for surgical prophylaxis could be listed as follows: 
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• Effective against suspected pathogens 
• Does not induce bacterial resistance  
• Effective tissue penetration 
• Minimal toxicity 
• Minimal side effects 
• Long half life 
• Cost effective 
 
Factors affecting the incidence of surgical site infection 
Previously it had been shown that if one classified the operation according to how «dirty» it 
was, then one could predict the likelihood of infection.  
Classification of operation:  
Operations can be categorised into four classes (table 1) with an increasing incidence of 
bacterial contamination and subsequent incidence of postoperative infections (3). 
Table 1: 
Clean  
Clean-contaminated 
Contaminated  
Dirty 
 
• Clean: elective surgery, no acute inflammation or transection of gastrointestinal tract, 
oropharyngeal, genitourinary, biliary or tracheobronchial tract, no break in aseptic 
technique, examples include craniotomy, orthopedic surgery, cardiothoracic and 
vascular surgery, antibiotic use is controversial, but routinely used. Examples in 
urologic surgery: orchiplexy and nephrectomy. 
• Clean-contaminated: urgent or emergent case that is otherwise clean, controlled 
opening of gastrointestinal tract, oesopharyngeal, genitourinary, biliary or 
tracheobronchial tracts, minimal spillage and/or minor aseptic technique break, 
examples include invasive head and neck surgery, cholecystectomy, urologic 
procedures, hysterectomy, orthopedic surgery with prosthesis, antibiotics are 
administered for prophylaxis. Examples in urologic surgery: endoscopic procedures in 
patients without indwelling catheters, radical cystectomy, and radical prostatectomy. 
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• Contaminated: any procedure in which there is gross soiling of the operation field 
during procedure, as well as surgery of open traumatic wounds (<4 hours old), 
examples include colorectal surgery with spillage, biliary or genitourinary tract 
surgery in the presence of infected bile or urine and clean or clean-contaminated 
procedures with major break in aseptic technique, antibiotics are administered for 
prophylaxis. Examples in urologic surgery: all the examples in urologic surgery above 
with concomitant urinary tract infection, bladder augmentation using colon, and 
surgery for vesicovaginal fistula. 
• Dirty: pus or abscess present, preoperative perforation of gastrointestinal tract, 
oropharyngeal, biliary, or tracheobronchial tracts, penetrating trauma (>4 hours old), 
examples include perforated appendicitis with abscess formation, antibiotics are 
utilized for treatment, therefore use is not considered prophylaxis. Examples in 
urologic surgery: surgery for pyonephrosis and surgery for colovesical fistula.  
 
It would be a simplification to estimate the wound infection rate only from this classification, 
but it gives a good idea of the likelihood of infection. Young fit patients with contaminated or 
dirty wounds may recover from the infection far more often than predicted from the wound 
classification in itself. Older patients with sick organs undergoing clean surgery might have a 
far higher infection rate. One must include the other factors that determine wound infection 
(and thus the need for antibiotic prophylaxis).  But first a definition of the surgical wound 
infections: 
• Infection identified by purulent or culture positive drainage isolated from any structure 
above the fascia in proximity to the surgical wound.  
• Deep infections are characterized by purulent drainage from subfascial drains, wounds 
bursting open, or abscess formation and involve adjacent sites manipulated during 
surgery 
• Wound dehiscence 
• Breakdown of the surgical wound  
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Figure 1: 
 
 
 
As the number of virulence of contaminating bacteria increase, so does the chance for the 
development of a postoperative infection. Surgical trauma to the tissues and the use of foreign 
material further potentiate the risk of infection, whereas systemic and local host immune 
mechanisms function to contain inoculated bacteria and prevent infection. Antibiotics in the 
tissues provide a pharmacologic means of defence that increase the natural host immunity. 
Bacterial resistance mechanisms may contribute to wound infection by enabling organisms to 
escape from the prophylactically administered antibiotics (4, 5). 
One can imagine the environment of the surgical wound as a balance or equation between 
different factors as shown in equation 1. An increase in the factors above the line also 
increases the chance for the development of a postoperative infection. General and local host 
immune mechanisms function to contain inoculated bacteria and prevent infection. 
Antibiotics in tissues help the natural host immunity.  
Equation: Determinants of surgical wound infections 
 
 
Risk of 
surgical 
wound    ˜ 
infection 
 
     Microbial                   Injury to             Foreign             Resistance to 
     concentration     X      tissue        X      material   X       preoperative  
     and virulence                                                                  antibiotics   
 
 
    General and local host immunity     X           Perioperative antibiotics 
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The identified risk factors: 
Incidence of a surgical wound infection depends on numerous factors specific to either the 
procedure itself or the individual patient. These include type of surgical procedure and 
bacterial load encountered, underlying medical condition of the patient, and surgical 
procedure (technique, duration, patient preparation, equipment preparation etc.) 
• Patient risk factors: Systemic factors such as diabetes, remote infections, 
corticosteroids, obesity, extreme of age, malnutrition, massive transfusion, and 
multiple preoperative co-morbid medical diagnosis: ASA class 3, 4 or 5.  The 
American Society of Anaesthesiologist (ASA) has devised a preoperative risk score 
based on the presence of co-morbidities at the time of surgery (Table 2) (6). An ASA 
score >2 is associated with increased risk of wound infection and this risk is additional 
to that of classification of operation and duration of surgery (3).  
 
Table 2: ASA classification of physical status 
ASA 
score 
Physical status 
1 A normal healthy patient 
2 A patient with a mild systemic disease 
3 A patient with a severe systemic disease that limits activity, 
but is not incapacitating 
4 A patient with an incapacitating systemic disease that is a 
constant threat to life 
5 A moribund patient not expected to survive 24 hours with or 
without operation 
 
• Patient risk factors: Local factors such as foreign body, electrocautery, injection with 
noradrenalin, wound drains, hair removal with razor, and previous irradiation of site. 
• Surgery-related factors: Such as type of procedure, site of surgery, emergent surgery, 
duration of surgery (>60-120 min), previous surgery, timing of antibiotic 
administration, placement of foreign body (hip/knee replacement, heart valve 
insertion, shunt insertion), hypotension, hypoxia, dehydration and hypothermia, 
surgeon preparation.  
• Wound-related factors: Magnitude of tissue trauma and devitalisation, blood loss, 
haematoma, wound classification, presence of drains, packs, or drapes as well as 
ischemia, and wound leakage. 
• Diagnostic procedure-related factors in urology: Ultrasound guided core biopsy of the 
prostate has become one of the most frequent diagnostic tools in urology, aimed at 
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diagnosing early prostate cancer. It is a quick, low-invasive procedure, but associated 
with a fairly high risk of infection (7, 8). Whereas cystoscopy rarely leads to an 
infectious complication (9). 
 
Table 3, is derived from a large epidemiological study and illustrates the relation between risk 
index and operation classification (10). The two risk factors used here are co-morbidity (ASA 
score >2) and duration of operation (>75th percentile):  
Risk index 0: When neither risk factor is present 
Risk index 1: When either one of the risk factor is present 
Risk index 2: When both risk factors are present 
 
Table 3: Probability of wound infection by type of wound and risk index (3) 
Operation 
classification 
Risk index 
 0 1 2 
Clean 1.0% 2.3% 5.4% 
Clean-contaminated 2.1% 4.0% 9.5% 
Contaminated 3.4% 6-8% 13.2% 
 
Here we can see that a clean operation with risk index 2 has a probability of 5.4 % for the 
likelihood of wound infection, as opposed to a contaminated operation with no risk index that 
has a probability of 3.4 % for wound infection.  
 
Indication for surgical antibiotic prophylaxis: 
This section reviews some aspects of the present controversies related to the prophylactic use 
of antimicrobial agents in urologic diagnostic and therapeutic procedure. Health care 
associated infections in urologic surgery are summarised in the following table: 
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Table 4: (11) 
•1 Surgical site infection 
a. Superficial  
b. Deep  
• Urinary tract infection 
a. Asymptomatic bacteriuria 
b. Symptomatic urinary tract infection 
c. Complicated urinary tract infection or febrile upper urinary tract 
infection 
d. Pyelonephritis 
• Blood stream infection  - septicaemia 
• Infection at a remote site 
 
The mostly feared complication in urologic surgery are deep surgical site infections, 
complicated urinary tract infection, pyelonephritis and septicaemia, all which represent a 
threat for the patient at an increased cost to society.  
A summary of the expected rates of infection related to some standard urological procedures 
are given in Table 5: 
Table 5: Expected rate of infection in conjunction with urologic surgery, expressed in % 
based mainly on references (11-15) 
Procedure Infection rates (reported/expected) 
 No antibiotic 
Prophylaxis 
With antibiotic 
prophylaxis 
 Bacteriuria/
UTI 
Febrile/ 
UTI 
Sepsis Rates of Febrile 
UTI/sepsis 
Diagnostic procedures 
Core biopsy of the prostate 20-53 5-10 1-5 <5 
Cystoscopy, urodynamic 
examination 
<20 <5 No 
data 
No impact 
Ureteroscopy No data  No impact 
demonstrated 
Endourologic procedures and ESWL 
ESWL <5 <5 1 Minimal impact 
TURP 6-70 5-10 <5 66-71% reduction 
Ureteroscopy (complicated) 
percutaneous stone surgery 
<38 4-25 <5  
Open surgery UTI SSI Sepsis  
Clean (nephrectomy) Catheter 
associated 
<2 No 
data 
No impact 
demonstrated 
Clean-contaminated (open urinary 
tract; bowel segment) 
Catheter 
associated 
5-10 <3 2-3 
Implant of prosthetic devices Catheter 
associated 
1-16 No 
data 
1-3 
No data indicates limited or no data available for that specific intervention. UTI= Urinary Tract Infection, SSI=Surgical Site 
Infection, ESWL= Extracorporeal shock wave lithotripsy, TURP= transurethral resection of the prostate 
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Administration of intravenous prophylactic antibiotics 
Appropriate antibiotic use for prevention of surgical wound infection includes the following: 
appropriate timing of administered agents and repeated dosing based on the length of the 
procedure and antibiotic half life. One may consider re-dosing if procedure exceeds 4 hours. 
The selection of the agent must be based on the procedure that is performed, and against the 
organisms most likely to be encountered. It must therefore cover both the endogenous 
organisms related to the type of surgical procedure performed, and the exogenous organisms 
introduced secondary to poor surgical technique. To avoid infection and decrease the 
potential for development of resistance, it is important to have the appropriate duration. 
Antibiotic prophylaxis is usually not indicated for patients with sterile urine, because the 
postoperative infection risk is small (16). 
• Choice of antibiotics; although a wide range of organisms can cause infection in 
surgical patients, surgical site infection is usually due to a small number of common 
pathogens. Thus the antibiotics selected for prophylaxis must cover the common 
pathogens (17) (table 6). Antibiotics used in antibiotic prophylaxis should be different 
from antibiotics used in treatment, but the drug in prophylaxis is also often used in 
treatment. Past history of a serious adverse event (allergy) and a comprehensive risk 
assessment should be part of the process of choosing the appropriate antibiotic (18).  
Table 6 
Escherichia coli, Proteus mirabilis, Enterococci, Pseudomonas spp., 
Staphylococci spp., Candida spp. 
 
       
      One can use many types of antibiotics for these criteria e.g. second-generation     
            cephalosporins, fluoroquinolones and aminopenicillins combined with a Beta- 
            lactamase inhibitor. High-risk patients and those who are allergic to Beta-lactams  
            can use aminoglycosides (19). 
 
• Timing of administration; because the antibiotic must be present in the tissue at the 
time the infecting organism arrives, timing is crucial. The period of risk for surgical 
site infection begins with the incision. The time taken for an antibiotic to reach an 
effective concentration in any particular tissue reflects its pharmacokinetic profile and 
the route of administration (20). Prophylaxis should be started within 30 minutes of 
the induction of anaesthesia. In theory, if prophylactic antibiotic is given prematurely 
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or too late, the result will be subeffective concentrations of the drug within the 
damaged and poorly perfused tissue because of shock, hypoxia, or vasoconstriction 
during surgery, thereby allowing survival and proliferation of the bacteria. Classen et 
al. demonstrated that patients receiving antibiotics either too early or postoperatively 
had more infections than patients receiving it prior to incision time (21). 
• Duration of prophylaxis; many drugs used in prophylaxis have relatively short half 
lives (1-2 hours in studies of normal volunteers). In such situations it may therefore 
seem logical to give an additional dose of prophylaxis during operation that last for 
more than 2-4 hours (22). However, in comparison with normal volunteers, patients 
undergoing surgery have slower clearance of drugs from their blood (23). Antibiotics 
should not be continued for over 24 hours (24). Procedures in which there is rapid 
blood loss and/or fluid administration will require more frequent prophylactic dosing.  
When focus of infection cannot be eliminated by the operation or in case of severe 
contamination, the administration of antibiotics may exceed for more than one day, it 
is then considered to be therapeutic not prophylaxis.  
• Intravenous administration of antibiotic prophylaxis immediately before or after 
induction of anaesthesia, 30 (-60) minutes before the incision, is the most reliable 
method for ensuring effective serum antibiotic concentrations at the time of surgery. 
But some oral antibiotics can be equally as effective as intravenous antibiotics (25).  
• The dose of an antibiotic required for prophylaxis is the same as that for the therapy of 
infection.  
 
Recommendation of prophylaxis according to the type of the urological procedure: 
The procedures are divided into three categorized groups; open procedures, endoscopic-
instrumental procedures, and diagnostic procedures, with regards to antibiotic prophylaxis 
(26). 
• Open operations: urinary tract including bowel segments, urinary tract without bowel 
segments, operations outside the urinary tract e.g. implants for penis and sphincter, 
testicular prosthesis, reconstructive genital operations 
• Endoscopic- instrumental operations: urethra, prostate, bladder, ureter and kidney, 
percutaneous litholapaxy, ESWL, laparoscopic operations 
• Diagnostic interventions: prostate biopsy (transrectal, perineal), urethrocystoscopy, 
ureterorenoscopy, percutaneous pyeloscopy, laparoscopic procedures 
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Antibiotic prophylaxis is usually recommended in urological surgery with the use of bowel 
segments. In urological surgery without the use of bowel segments, antibiotic prophylaxis is 
not generally required unless the patient has an increased risk of infection (page 8: identified 
risk factors), or before a TURP if there is a history of a urinary tract infection. For urologic 
procedures outside the urinary tract, prophylaxis is generally not recommended. Exceptions 
are in long reconstructive genital operations or with implant surgery. In endoscopic- 
instrumental operations, perioperative antibiotic prophylaxis is recommended only in cases 
with increased risk of infection. Diagnostic interventions: perioperative antibiotic prophylaxis 
is generally recommended in transrectal prostate biopsy with a thick needle. In the other 
diagnostic procedures antimicrobial prophylaxis is only recommended in high-risk patients. If 
the patient has indwelling catheter, stent, nephrostomy etc. postoperatively, prolongation of 
perioperative prophylaxis is contraindicated.       
 
Controversies in antibiotic prophylaxis in urology: 
Although there are a number of reports that show the benefit of the use of prophylaxis for 
reduction of postoperative mortality (27, 28), it is important to underline that urologic 
diagnostic and therapeutic procedures can induce surgical site infections, bacteriuria, 
pyelonephritis and septicaemia in a substantial number of patients, too great to be neglected. 
As patients are different and have various risk factors, a careful assessment of the patient and 
its individual risk is crucial. The pathogens and their susceptibility pattern vary extensively in 
Europe so that no clear European recommendations as for the choice of antibiotics can be 
given. Prophylaxis and treatment should be adjusted according to the local resistance pattern. 
The resistance situation in Norway is favourable; therefore old fashioned and cheap 
antibiotics can be used (34). Basic principles of antibiotic prophylaxis in terms of timing, 
mode of administration and length of regiment apply for urologic interventions. It is therefore 
the task of the urologists to carefully assess each individual patient and procedure to make a 
choice for an optimal prophylaxis (11). The final decision regarding the benefits and risks of 
prophylaxis for an individual patient will depend on:  
• The patient’s risk of surgical site infection 
• The potential severity of the consequences of surgical site infection 
• The effectiveness of prophylaxis in that operation 
• The consequences of prophylaxis for that patient 
 13
Results from the antibiotic prophylaxis registration at Aker University Hospital, Oslo 
Urological University Clinic: 
177 surgeries conducted during a six-month period were evaluated by reviewing medical, 
anaesthetic and nursing records, and medication charts for each patient. The antibiotic choice, 
duration of prophylaxis, dose and timing of the first dose was recorded on special schemes. 
The majority of the patients were males (85 %) and the mean length of hospital stay was 8.7 
[1, 44] days. Most of the surgeries were elective. Patients, who were under treatment with 
antibiotics before the surgery, accounted for 8.6 % (15) of the total procedures, and they were 
excluded from prophylaxis analysis. If no antibiotic prescriptions had been recorded, it was 
assumed that antibiotics were not given. If data on a certain parameter of the antibiotic 
prescription were lacking, this was classified as missing data on this parameter only. The 
operations were categorized as on pages 12-13. Group A is open operations: urinary tract 
including bowel segments, urinary tract without bowel segments, operations outside the 
urinary tract e.g. implants for penis and sphincter, testicular prosthesis, reconstructive genital 
operations. Group B is endoscopic- instrumental operations: urethra, prostate, bladder, ureter 
and kidney, percutaneous litholapaxy, ESWL, laparoscopic operations.  Group C is 
urethrocystoscopy, and group D the testicular operations. Table 7 shows the timing of the 
antibiotic prophylaxis given in the different groups. Preoperative is defined as before time of 
incision (within 24 hours); perioperative is defined between time of incision and the end of 
the operation. Postoperative is defined as the time after the operation is finished. In group A, 
19 (27.5 %) procedures were given preoperative antibiotic prophylaxis and 13 (18.8 %) were 
given prophylaxis after the time of the first incision. In group B, 34 (43 %) procedures was 
given preoperative antibiotic prophylaxis and 25 (31.6 %) were given prophylaxis after the 
time of the first incision. In group C no prophylaxis was given. In group D, there is usually no 
indication for giving prophylaxis, but in the 3 (12 %) cases where prophylaxis was given, the 
indication for giving prophylaxis was because of prosthesis, scrotal haematoma and traumatic 
capsule rupture. In 16 (9 %) cases, timing could not be evaluated, either because the moment 
of the first incision, or the moment of the administration of the first antimicrobial dose, could 
not be retrieved from the records.  
 
 
 
 
Table 7: 
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 A B C D Total 
Preoperative 19 34  2 55 
Perioperative 9 3   12 
Postoperative 4 22  1 27 
Non given 24 15 2 19 60 
No data 1 4 1 1 7 
Excluded 12 1 1 2 16 
Total 69 79 4 25 177 
 
Table 8 shows the duration of the antibiotic prophylaxis in the days after the surgery. In group 
A, the mean duration of antibiotic prophylaxis after the operation was 2.5 days with a range 
of 0 days and 11 days. The same mean duration for group B and D, was respectively 7.2 days  
< 0, 14 > and 2.5 days < 1, 7 >.                      
Table 8: 
 A B D 
Mean duration  
(in days) 
 <Range> 
2.5  
 
< 0, 11 > 
7.2 
 
< 0, 14 > 
2.5 
 
< 1, 7 > 
 
Table 9 shows the drug and the first dose given for prophylaxis in the 6 different groups. 
Antibiotic prophylaxis is used in all surgeries with the use of bowel segments and in 96% of 
laparoscopic radical prostatectomy surgeries. Group IV and V; contain many different types 
of surgeries and that may to some extent explain the wide amount of variation in the different 
types of antibiotics chosen for the prophylaxis. In two of the procedures, antibiotic 
prophylaxis with Ampicillin and Gentamicin against endocarditis was used. Metronidazol, 
Gentamicin, Ampicillin, and Trimethoprim were the drugs most frequently used in 
combination with other antibiotics. The most common drug used was Trimethoprim. As one 
can see from the table, there are for example 7 different regiments for prophylaxis just for 
group II, excluding the endocarditis regiment and the doses varies.  In conclusion, use of 
antibiotics follows the patterns of recommendations, but there are still differences in the 
dosage and choice of drugs. 
 
 
Table 9: I Surgery with the use of bowel segments, II Laparoscopic radical prostatectomy, III Testicular operation, IV Open surgeries, 
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V Endourological, VI Urethra surgery, genital reconstruction 
Indications I II III IV V VI 
Drug (first dose given):             
Yes 10 50 4 13 11 6
No  1 19 21 15 6
Unknown   1         
Metronidazol + Doxycyclin             
1000 mg x 2 + 200 mg x 1 1       
1000 mg x 1 + 200 mg x 1 6   1    
1500 mg x 1 + 200 mg x 1 1       
1500 mg x 1 + 400 mg x 1 2           
Trimethoprim             
160 mg x 1  40  1  1
160 mg x 2  4   1 3
300 mg x 1         1   
Ofloxacin             
200 mg x 1  1      
300 mg x 1   1 1   1   
Trimethoprim + Ofloxacin             
160 mg x 1 + 300 mg x 1   1         
Metronidazol + Cefuroxim             
1000 mg x 1 + 1500 mg x 1  1      
1500 mg x 1 + 1500 mg x 1      1     
Ampicillin             
1000 mg x1      1
1000 mg x 4     1   
2000 mg x 2  1      
2000 mg x 3       1     
Trimethoprim + Ampicillin + Gentamicin             
160 mg x 1 + 2000 mg x 2 + 320 mg x 1   1         
Trimethoprim + sulfamethoxazole –
Trimethoprim 
            
160 mg x 2 + 2 tablets x 2           1
Ciprofloxacin             
250 x 1    1    
250 mg x 2   1     
400 mg x 1    1 1 1
400 mg x 4       1     
Cefalotin             
2000 mg x 1     1       
Erythromycin             
500 mg x 2     1       
Mecillinam             
400 mg x 1         2   
Gentamicin             
320 mg x 1       1 2   
Cefuroxim             
1500 mg x 1         1   
Gentamicin + Mecillinam             
440 mg x 1 + 200 mg x 3         1   
Cefalexin             
1000 mg x 2       1     
Ciprofloxacin + Cefuroxim             
500 mg x 2 + 1500 mg x 1       1     
Ampicillin + Gentamicin             
2000 mg x 1 + 300 mg x 1       1     
Ciprofloxacin + Metronidazol             
400 mg x 1 + 1500 mg x 1       1     
Ampicillin + Metronidazol             
2000 mg x 1 + 1500 mg x 1       1     
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Discussion 
The use of antimicrobial agents is different from the use of other pharmaceutical agents. It is 
not only based on the characteristics of a patient and a drug, but also on the characteristics of 
the bacteria or the infection one is trying to prevent. Activity of the antibiotic drug is 
counteracted by the development of resistance by the pathogen, but also by exposed 
colonising flora. Antimicrobial use is a major determinant for the development of resistance 
(29). It is therefore important to optimize the use of antimicrobial drugs (30).   
 
The major problem in collecting the data from the patient records was lack of documentation 
of the exact time for when the prophylaxis was given. To perform an audit on patient records 
is also time consuming. Good planning, knowing what to look for, and making distinct goals 
are of great importance before starting with the audit. There was no clinical guideline for 
antibiotic prophylaxis at Aker University Hospital (Urology department), when we performed 
the study. 
 
From the data collected, 29 of 48 (60.4 %) patients undergoing laparoscopic radical 
prostatectomy received prophylaxis preoperative, 19 of 48 (39.6 %) patients received 
prophylaxis postoperatively, and one received none for the same procedure. There was a lack 
of a clear indication in the timing of the first dose; this may possibly be related to logistics in 
the surgical group, the arrival time at the operating rooms, the type of anaesthesia used, or 
most importantly lack of guidelines. 
 
Antibiotic prophylaxis should not be continued for over 24 hours (24). Many studies have 
shown that a single dose of an antimicrobial drug is sufficient for most surgical procedures. 
Inappropriate use of prophylaxis is often due to prolonged administration. The mean duration 
of prolonged prophylaxis at Aker was too long. Excessive duration of antibiotic use during 
the postoperative period may be due to the surgeon’s thought of the necessity of providing 
«extra protection» due to risk from serum lines, tubes or catheters, or because of the 
impossibility of differentiating infection from contamination and inflammation from another 
site.   
There are also differences in the dosage and choice of drugs applied for the same procedures. 
 
Clinical guidelines are becoming increasingly popular as a mean of influencing clinicians’ 
practice. This is particularly true of guidelines for antibiotic usage. They have several aims: to 
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reduce variations in the methods and standards of care; to improve the appropriateness of 
care; to improve the quality of care; to reduce the costs of care; to improve the cost-
effectiveness of care; in the case of antibiotic guidelines, to control, or even reduce, the levels 
of resistant organisms; to serve as educational tools; and to promote evidence-based decision 
making (31). It is therefore important to introduce clinical guidelines for antibiotic usage.  
 
Given the recent worldwide escalation in resistance and the overwhelming evidence of much 
over-use of antibiotics (and thus unnecessary resistance), the practical and essential approach 
to the control of antibiotic resistance is to control antibiotic use. However knowledge about 
existing guidelines and alignment of the guidelines according to current evidence is not 
enough to guarantee good antibiotic use in either surgical prophylaxis or therapeutic 
intervention.  
 
The most recent guidelines from European Association of Urology came out in March 2006 
(32). They also emphasize the need for evidence-based guidelines, because of controversies in 
antibiotic prophylaxis within urology. 
 
After this thesis, a guideline in urology at Aker University hospital was issued in June 2006 
(33). 
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